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Using a pig ear skin model, it is demonstrated that silica 
vesicles show higher skin safety compared to dense silica 
nanoparticles with similar sizes. A hydrophobic UV blocker is 
dioxane solution. Furthermore, a fraction of UV light is scattered 
to  skin.  Li  et  al.  reported  the  incorporation  of  crystalline 
50  benzophenone-3 in mesoporous silica aerogel, which show higher 
22 
10 efficiently dispersed in silica vesicles in an amorphous state, 
leading to ultrahigh UV attenuating efficiency and a sun 
protection factor of 100 in sunscreen formulation. 
 
Introduction 
 
In recent years, nanomaterials have been widely used for modern 
15 pharmaceutical  and  cosmetic  applications.1-3   The  safety  of 
nanoparticles (NPs) is an important aspect for both scientific and 
public communities.3-5 Various NPs have been investigated for 
their skin safety. With the protection of stratum corneum (SC), 
most NPs such as TiO2 (35-250 nm), ZnO (60 nm) and Au (10-60 
20  nm) can hardly penetrate to deep SC and epidermis.6-8  However, 
skin damage from hair removal or sunburn can enhance the 
penetration of NPs.6, 9, 10  With increasing topical applications of 
silica NPs, their skin safety has also drawn much attention. The 
size-dependent skin penetration behaviour of dense silica NPs has 
25  been investigated in mice11,  12  and human skin models.13  It is 
found that dense silica NPs with diameters smaller than 75 nm 
tend to penetrate damaged human skin, questioning their 
suitability in cosmetic formulations. Compared to their solid 
counterpart,  porous  silica  NPs  have  lower  density  and  wider 
30  applications.1   Whilst  the  toxicology  of  silica  NPs  has  been 
studied via various routes,14  the skin safety of porous silica NPs 
in comparison with solid ones has not been reported. 
Sunscreens  are  the  most  convenient  and  commonly  used 
topical product to  prevent skin damage  from ultraviolet  (UV) 
35  light  irradiation.15-17   Commercial  sunscreens  contain  multiple 
organic UV absorbing substances (so-called blockers) as active 
ingredients.18 Improvement on the dispersibility/solubility of 
hydrophobic UV blockers in water-based sunscreen formulations 
(>  60%  water)  is  crucial  for  UV  attenuating  efficiency.  For 
40  example, nanoparticulates have been prepared by micronization 
of  crystalline  organic  UV  blockers  in  sub-micron  scale  to 
enhance  their  efficiency.19-21   Herzog  et  al.  micronized  2,2'- 
methylenebis-(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethyl- 
butyl))phenol (MBBT, a broadband and hydrophobic UV blocker) 
45  crystals by a wet-milling method with the addition of surfactants. 
MBBT nanoparticulates (38-169 nm) show higher UV extinction, 
however the optimized result is still 25-33% lower than MBBT- 
UV-attenuating efficiency than large benzophenone-3 crystals. 
Nevertheless, 60% of the UV extinction is contributed by silica. 
In another example, hybrid organosilica particles were prepared 
by incorporating UV absorptive chromophores in the network, 
55  showing good UV absorbance compared to chromophore in true 
solution.23 However, this method is not applicable to UV blockers 
incapable of crosslinking with silica precursors. To date, a facile 
method to achieve UV-attenuating efficiency of hydrophobic 
organic UV blockers comparable to that in true solution is still a 
60  challenge. 
In the present work, two types of silica NPs have been 
synthesized with similar size of ~ 50 nm, including silica vesicles 
(SVs) with a hollow structure and solid Stöber spheres with a 
dense structure. Hair-removed pig ear skin is utilized as an ex 
65  vivo model for skin safety evaluation. Compared to dense Stöber 
spheres, it is demonstrated that SVs with a lower density are skin 
friendly and penetrate only in the upper part of SC (Fig. 1). It is 
also shown that MBBT loaded in SVs exists in an amorphous 
state,    which    exhibits    superior    UV-attenuating    efficiency 
70  comparable to MBBT dissolved in organic solvents and a high 
sun protection factor (SPF) of 100 in sunscreen formulations. 
 
 
Fig.1 Schematic representation of sunscreen formulation containing 
nanodispersed UV blocker MBBT in skin-friendly SVs with ultrahigh 
75 UV-attenuating efficiency. 
 
Results and Discussion 
  
, 
 
 
SVs were synthesized utilizing a vesicle templating method24 
while dense spheres with similar particle sizes were synthesized 
using Stöber method25 (see Supporting Information, SI). Figs. 2A 
and C are the field-emission scanning electron microscope (FE- 
5  SEM)  images  of  SVs  and  Stöber  spheres,  both  showing  a 
spherical morphology with a uniform particle size of ∼ 50 nm 
(denoted as SV-50 and SS-50, respectively). To observe the pore 
structure of SVs, transmission electron microscopy (TEM) was 
employed.  SV-50  show  a  hollow  structure  with  an  average 
10  diamter of 45.9±3.0 nm, wall thickness of ∼ 6 nm and hollow 
cavity size of ~ 34 nm (Fig. 2B). In contrast, SS-50 show a dense 
nature with particle size of 52.3±2.2 nm (Fig. 2D). Both SV-50 
and SS-50 are negtively charged in water with the ζ potential of - 
16.6±0.5 and -32.8±0.6 mV, respectively (Table S1). 
 
15    
Fig.2 FE-SEM (A and C), TEM (B and D) images of calcined SV-50 and 
SS-50, respectively. 
 
In order to evaluate the skin penetration of silica NPs, both 
SV-50 and SS-50 were modified with amino- group, after which 
20 fluorescein-5-isothiocyanate    (FITC)    was    labelled.    After 
conjugation of FITC, SV-50 and SS-50 show similar zeta- 
potential (+17.6±0.5 and +20.3±0.7 mV, respectively, Table S1) 
and hydrodynamic diameter (122.4 and 141.8 nm, respectively, 
Fig. S1). The increased sizes can be attributed to the aggregation 
25  caused  by  the  surface  modification  process.13    With  similar 
surface chemistry and hydrodynamic size after the last FITC 
modification step, we further compare the difference of skin 
penetration behaviour between SV-50 and SS-50. 
Ex vivo pig ear skin after hair removal was used as it is a 
30 suitable  model  for  simulating  human  skin  in  sunscreen 
applications.26, 27 FITC labelled silica NPs were well dispersed in 
water (1 mg cm-3) and applied to the excised skin samples at a 
dose of 2 mg cm-2. Confocal microscopy was used to directly 
observe the penetration depth of FITC modified NPs after topical 
35  application. From skin side section (Fig. 3A-C), it is observed 
that the penetration depth of SV-50-FITC (green fluorescence) is 
< 5 μm (Fig. 3A1), but much deeper (~ 20 μm) for SS-50-FITC 
(Fig. 3A2). The red signal comes from skin reflectance (Fig. 3B). 
After merged and calibrated the depth with the skin reflectance, it 
40  is noted that SV-50 with a hollow structure mostly distribute in 
the upper part of SC layer (Fig. 3C1). In comparison, SS-50- 
 
FITC show a much deeper skin penetration of ~20 μm (Fig. 3C2) 
which equals to the thickness of SC layer (15-20 μm), indicating 
that  SS-50-FITC  has  reached  the  boundary  between  SC  and 
45  viable epidermis. From the confocal images of the cross section 
(Fig. 3D), the strong green fluorescence with gash shape in the 
middle of skin indicates that the silica NPs tend to aggregate in 
the skin fold/furrow. 
 
 
50       Fig.3 Confocal microscope images of ex vivo pig ear skin after treated 
with SV-50 (left) and SS-50 (right) in water suspension: (A) side section 
with green fluorescence from FITC-labelled NPs, (B) side section with 
red fluorescence from skin reflectance, (C) side section merged, and (D) 
cross section merged. 
 
55  At  the  same  dose  of  SV-50  and  SS-50,  different  particle 
numbers were applied onto the skin due to their porous/solid 
nature. Thus, the observed difference in fluorescence may be 
attributed to either the particle numbers, or the nature of a hollow 
or solid structure. In order to elucidate this problem, the density 
60  of two particles is estimated. The density of SS-50 is chosen as 
that of amorphous silica (1.70 g cm-3  SI, Calculation of apparent 
density of nanoparticles).28 The apparent density of SV-50 is 
estimated using a simplified model (Fig. S2), which is 1.01 g cm-3, 
lower than that of SS-50. The actual density of SV-50 will be 
65  even lower if the wall porosity is further considered. 
The particle number applied on ex vivo pig skin in Figure 2 
calculated from apparent density is 3.90×105  and 1.57×105  μm-2 
for SV-50-FITC and SS-50-FITC, respectively (Table S1). 
Statistic skin penetration values of two particles are quantified by 
70 integrating the fluorescence density from 10 skin regions. The 
integrated fluorescence density normalized by particle number 
shows that both NPs have a decreasing distribution as a function 
of skin depth (Fig. S3). The integrated density of SV-50-FITC 
decreases from 1.99×10-2  (relative fluorescence unit per particle 
75  number) at the skin surface to baseline value 0.20×10-2  at skin 
depth of 5 μm. In comparison, SS-50-FITC is widely distributed 
in the range of 0-15 μm from the skin surface in the integrated 
  
 
density from 3.06×10-2 to 0.29×10-2, confirming that hollow SVs 
with a lower density indeed show lower skin penetration ability 
and thus higher skin safety, which is beneficial for applications in 
topical products.  Considering  the  advantages  including  porous 
5  nature  and  skin  friendness,  SVs  were  chosen  to  encapsulate 
MBBT in the following tests. 
A  rotary  evaporation  method  was  utilized  to  encapsulate 
MBBT into SVs using MBBT-ethyl acetate (EA) solution with 
MBBT:SV   ratio   of   0.6:1,   0.8:1   and   1:1.   The   MBBT-SV 
10  composites  are  denoted  MBBT-SV-X  where  X  stands  for  the 
ratio of MBBT:SV. The actual loading amount of MBBT can be 
calculated by the weight loss from thermogravimetric analysis 
(Fig. 4A). Pure MBBT shows complete weight loss of 99.8% at 
900 °C. Pure SV-50 shows 1.70% weight loss from the adsorbed 
15  moisture. The weight losses of MBBT-SV-X are 38.3, 44.9 and 
50.8% for X = 0.6, 0.8 and 1.0, respectively. Accordingly, the 
loading amount of MBBT-SV-X (X = 0.6, 0.8 and 1.0) is 
calculated to be 37.3, 44.0 and 50.0%, respectively, indicating 
that rotary evaporation can achieve complete loading (~ 100%) of 
20  MBBT. 
Figure  S4A  shows  the  Fourier  transform  infrared  (FTIR) 
spectrum of pure MBBT. Eleven obvious characteristic peaks at 
737, 1215, 1256, 1310, 1344, 1389, 1458, 1928, 2889, 2953 and 
3068 cm-1  can be attributed to C-H, C-O, C-O of CH3-O for 
25  phenyl, -CH2-, C=C of benzene, -CH3  and phenyl bonding. The 
spectrum of SV-50 shows a characteristic peak at 810 cm-1  that 
can be attributed to ν(Si-O),29  and broad peak in the range of 
1050-1200 cm-1 that can be attributed to –Si-O-Si bonding.30, 31 In 
the spectra of all MBBT-SV-X (C-E), besides overlapping with 
30  the characteristic peaks of silica, characteristic peaks 737, 1310, 
1344, 1389, 1458, 2889 and 2953 cm-1 can still be observed. The 
FTIR spectra confirm the successful encapsulation of MBBT. 
The crystalline state of MBBT before and after encapsulation 
is characterized by wide angle X-ray diffraction (WA-XRD, Fig. 
35  4B). The WA-XRD pattern of pure MBBT (a) shows a sharp 
peak at 14.3° and other characteristic peaks in the range of 15.0- 
28.6°, indicating pure MBBT is in a crystalline state. SV-50 (b) 
shows a broad peak centred at ~ 22° which can be attributed to 
amorphous   silica.   Sharp   characteristic   peaks   could   not   be 
 
dispersed form by utilizing the rotary evaporation technique. 
 
60    
Fig.4 (A) TGA profiles, (B) wide angle XRD patterns and (C) DSC 
profiles of (a) pure MBBT, (b) calcined SV-50, (c) MBBT-SV-0.6, (d) 
MBBT-SV-0.8 and (e) MBBT-SV-1.0. (C, f) is the DSC curve for 
physical mixture of MBBT and SV-50. 
 
65  FE-SEM  was  used  to  directly  observe  the  morphology  of 
MBBT-SV-X. If pure MBBT/ethyl acetate solution is used for 
rotary evaporation, large crystalline MBBT with the size of 1-5 
μm (Fig. S5A) is formed. In the same magnification, pure SV-50 
shows aggregations of small particles (B). MBBT-SV-0.6 shows 
40 observed in the WA-XRD pattern of MBBT-SV-0.6 or MBBT- 
SV-0.8 (c or d), indicating no crystalline MBBT is formed in 
these two samples. Beside the broad peak at 22°, another two 
broad peaks at ~ 14 and 43° are observed, attributed to MBBT. In 
comparison, MBBT-SV-1.0 (e) shows broad peaks at 14-20 and 
45  43°,  as  well  as  sharp  peaks  (14.3,  16.2,  18.2  and  23.0°) 
overlapped with the broad peak from amorphous SVs. This 
phenomenon indicates that a fraction of crystalline MBBT exists 
in MBBT-SV-1.0. 
The crystallization behaviour of MBBT-SV-X has also been 
50  studied by differential scanning calorimetry (DSC, Fig. 4C). Pure 
MBBT displays a sharp endothermic peak at 196 °C which is the 
melting point of crystalline MBBT.21 Similar to pure SV-50, 
MBBT-SV-0.6 and MBBT-SV-0.8 show no obvious peaks in the 
range   of   25-350   °C,   indicating   an   amorphous   state.32    In 
55  comparison, a small endothermic peak at 196 °C is observed for 
MBBT-SV-1.0 as well as a physical mixture of MBBT and SVs 
(f), indicating the existence of crystalline MBBT structure. It is 
concluded  that  MBBT was  encapsulated  into  SVs  in  a  nano- 
70  exactly the same morphology as pure SV-50, and no obvious 
crystals of MBBT can be observed in either low (C) or high (D) 
magnification, indicating the MBBT is successfully encapsulated 
in the cavity of SVs. When the ratio of MBBT:SV increases to 
1:1, small crystals (F, indicated by white arrow) appear. From 
75  nitrogen sorption analysis (Table S2), the total pore volume of 
SV-50 decreases from 1.22 cm3 g-1 to 0.39, 0.30 and 0.26 cm3g-1 
after encapsulation of MBBT (X= 0.6, 0.8 and 1.0), respectively, 
indicating the mesopores of SV-50 are occupied by MBBT. 
Barrett–Joyner–Halanda (BJH) pore size distribution (PSD) curve 
80  of SV-50 (Fig. S6B) calculated from the adsorption branch (A) 
shows a peak at 39.5 nm for the cavity size. After encapsulation 
of MBBT, the PSD curve of MBBT-SV-0.6 shows a weak and 
broad peak centred at ~ 44 nm, while this peak cannot be found 
for MBBT-SV-0.8 or MBBT-SV-1.0, indicating the occupation 
85  of cavity by MBBT. In the case of MBBT-SV-1.0, the feeding 
ratio of MBBT exceed the theoretical loading capacity of SVs 
(SI), thus crystalline MBBT is formed outside the mesopores of 
SVs. The ζ potential of SV-50 after encapsulation of MBBT 
increases from -16.6 mV to -0.53 and -0.51 mV (MBBT-SV-0.6 
  
 
and MBBT-SV-0.8, respectively), indicating a fraction of 
amorphous MBBT is attached on the outer surface of SV-50. For 
MBBT-SV-1.0 with crystalline MBBT growing outside the SV 
cavity,  the  ζ  potential  further  increases  to  0.02  mV.  The 
5  hydrodynamic size of MBBT-SV-0.6 slightly increases to 141.8 
nm (Fig. S8) after encapsulation. 
Sunscreen   formulations   are   preferentially   water   based. 
However, most of the organic UV blockers are hydrophobic and 
have   very   poor   dispersibility/solubility   and   lowered   UV- 
10 attenuating efficiency in water. Consequently, the addition of 
hazardous dispersing agent is often required.21 With hydrophobic 
MBBT nanodispersed within the hydrophilic silica, MBBT-SV- 
0.6 can be well dispersed in water without adding any dispersing 
agents as demonstrated in Fig. S7A, showing the advantage of 
15 using SVs in the formulation of a pure water-based sunscreen 
formulation. 
The UV-attenuating efficiency of MBBT solution/suspension 
was measured by UV-Vis spectrometry. Fig. 5 shows a series of 
extinction spectra calculated from direct UV-Vis transmittance 
20  (Equation  S2).21   The  direct  extinction  is  contributed  by  three 
fractions:  absorbance,  forward  and  backward  scattering.  Pure 
MBBT (green) shows no UV extinction due to the large crystal 
size and insolubility in water. MBBT-EA solution (0.004%, black) 
shows  broad  extinction  in  the  range  of 280-375  nm and  two 
25  characteristic peaks at 304 and 346 nm for MBBT.19, 20  In EA 
solution,  MBBT  contributes  no  scattering  (EFS   =  EBS   =  0). 
MBBT-SV-0.6/water suspension with the same concentration of 
MBBT (red) shows equivalent extinction to that of MBBT-EA 
solution, except slightly lower in the range of 333-356 nm, which 
30  is much better than MBBT prepared by other methods.21 
The superior UV-attenuating efficiency of MBBT-SV 
composites should be mainly attributed to the unique 
nanostructure of MBBT because SVs show negligible UV 
extinction (Fig. S9). In the range of 360-400 nm, MBBT-SV-0.6 
35  shows an increasing extinction contributed by UV scattering from 
nanodispersed MBBT.21 In addition to MBBT, the silica structure 
is also important. If SVs were removed by dissolving silica in 
Na2CO3 solution (0.6 M), visible white particles can be observed 
in the suspension (Fig. S7B), indicating the formation of large 
40 aggregates of MBBT without the protection of siliceous shells. 
Such large aggregates exhibit dramatically lower UV extinction 
(blue curve, Fig.5). Our results indicate that the silica shell of 
SVs prevents the aggregation of nanodispersed MBBT and 
provides  good  water  dispersity,  both  advantageous  for  the 
45 excellent   UV   attenuating   performance   in   a   pure   water 
formulation. 
 
Fig.5 A series of extinction spectra calculated from direct UV-Vis 
transmittance of solution/suspension with MBBT concentration of 
50   0.004% in 1 cm quartz cell, (black) MBBT in ethyl acetate solution, (red) 
MBBT-SV-0.6 in water suspension, (blue) MBBT-SV-0.6 in water 
suspension after dissolving silica by 0.6 M Na2CO3 solution, (green) pure 
MBBT in water suspension. 
 
Although MBBT is an excellent UV blocker with broadband 
55  spectrum and scattering ability, the forward scattering of UV light 
towards skin is a drawback for MBBT crystals.21 In order to 
evaluate the forward scattering of MBBT-SV-0.6, the diffuse 
extinction (absorption and backward scattering) was also 
calculated from the diffuse UV-Vis transmittance by Equation S3 
60 (Fig. S10 red). By subtracting diffuse from direct extinction 
spectra, the contribution from forward scattering can be obtained 
(blue). The fraction of forward scattering of MBBT-SV-0.6 in 
total UV-attenuating efficiency (Fig. S11) is far lower than 
crystalline MBBT in submicron size.21 It is revealed that by using 
65  amorphous MBBT nanodispersed in SVs, the UV light scattered 
to skin can be significantly reduced. 
A cream based sunscreen formulation containing MBBT-SV- 
0.6 with a MBBT ratio of 1, 2, 4 and 8% has been prepared 
without adding dispersing agent (Table S3). The in vitro SPF 
70  value  of the  MBBT-SV-0.6  formulations  was  calculated  from 
their diffuse transmittance33, 34 by Equation S4. Formulations 
containing pure crystalline MBBT show very low in vitro SPF 
value of 1.22-1.86 (MBBT 1-8 w/w%). Formulations containing 
corresponding amount of SV-50 show in vitro SPF of 1.33-1.92. 
75  MBBT-SV-0.6 with a MBBT ratio of 1, 2, 4 and 8 w/w% show 
high in vitro SPF value for 2.29, 16.25, 40.71 and 100.34 in 
formulations, respectively. Despite the slight difference of 
formulation recipes, sunscreen formulations containing 
nanodispered MBBT show much higher UV protection ability 
80  compared  to  that  containing  MBBT  crystals  with  the  same 
concentrations (Table 1).35 
  
b 
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Table 1. In vitro SPF of formulations containing MBBT-SV-0.6. 
 
 
MBBT 
Content 
( / %)   
 
 
MBBT 
 
 
SV-50 
 
 
MBBT-SV-0.6 
 
Calculated SPF 
of MBBT 
t l 35   1 1.23 1.33 2.29 - 
2 1.22 1.33 16.25 4.9 
4 1.45 1.58 40.71 6.5 
8 1.86 1.92 100.34 11.3 
 
Conclusions 
 
In conclusion, we have demonstrated that silica vesicles with a 
hollow structure show higher skin safety in ex vivo pig ear skin 
5 compared  to  solid  silica  nanoparticles.  A  hydrophobic  UV 
absorber, MBBT, has been encapsulated in silica vesicles in an 
amorphous state. The nanodispersed nature of MBBT confined in 
the cavity, the non-aggregated behaviour of MBBT protected by 
the siliceous shells, and the well water dipersibility of MBBT-SV 
10  composites due to the hydrophilic nature of silica all contribute to 
a high UV-attenuating efficiency and sun protection factor. Our 
findings provide fundamentally important knowledge for the 
design of effective and safe topical products in cosmetic and 
pharmaceutical applications. 
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